Involvement of Bcl-XL deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells

Oncogene

Volumn 25, Issue 18, 2006, Pages 2656-2665

  Chang, C Y ^a   Lin, Y M ^a   Lee, W P ^b   Hsu, H H ^a   Chen, E I T ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Bcl XL; Deamidation; E1A; Rb

Indexed keywords

ALKALI; ALKYLATING AGENT; CASPASE 3; CISPLATIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOCHROME C; DNA FRAGMENT; E1A PROTEIN; OLOMOUCINE; PHOSPHATASE; PROTEIN BCL XL; RETINOBLASTOMA PROTEIN; RNA; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOSOL; DEAMINATION; DOSE RESPONSE; DRUG SENSITIZATION; FEMALE; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOCHONDRION; MOLECULAR CLONING; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

ADENOVIRUS E1A PROTEINS; AMIDES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CASPASES; CISPLATIN; FEMALE; HUMANS; MUTAGENESIS, SITE-DIRECTED; OVARIAN NEOPLASMS; RETINOBLASTOMA PROTEIN; TRANSFECTION; TUMOR CELLS, CULTURED;

ADENOVIRIDAE;

EID: 33646337675     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209294     Document Type: Article

References (35)

1. Abraham RT, Acquarone M, Andersen A, Asensi A, Belle R, Berger F et al. (1995). Biol Cell 83: 105-120.
2. Agarwal R, Kaye SB. (2003). Nat Rev Cancer 3: 502-516.
3. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace Jr AJ. (2000). Cancer Res 60: 6101-6110.
4. Brader KR, Wolf JK, Hung MC, Yu D, Crispens MA, van Golen K et al. (1997). Clin Cancer Res 3: 2017-2024.
5. Chattopadhtyay D, Ghosh MK, Mal A, Harter ML. (2001). J Viol 75: 9844-9856.
6. Chau BN, Wang JYJ. (2003). Nat Rev Cancer 3: 130-138.
7. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC et al. (1992). Proc Natl Acad Sci USA 89: 4549-4553.
8. Chen IT, Smith ML, O'Connor P, Fornace Jr AJ. (1995). Oncogene 11: 1931-1937.
9. Deng J, kloosterbooer F, Xia W, Hung MC. (2002). Cancer Res 62: 346-350.
10. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I et al. (2002). Cell 111: 51-62.
11. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I et al. (2003). Cell 115: 503.
12. Dignam JD, Lebovitz RM, Roeder RG. (1983). Nucl Acids Res 11: 1475-1488.
13. Duelli DM, Lazebnik YA. (2000). Nat Cell Biol 2: 859-862.
14. Frisch SM, Mymryk JS. (2002). Nat Rev Mol Cell Biol 3: 441-452.
15. Lee WP, Tai DI, Tsai SL, Yeh CT, Chao Y, Lee SD et al. (2003). Cancer Res 63: 6229-6236.
16. Lee WP, Wen Y, Varnum B, Hung MC. (2002). Oncogene 21: 329-336.
17. Nevins JR. (1992). Science 258: 424-429.
18. Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T. (1998). Cancer Res 58: 3331-3338.
19. Robinson NE. (2002). Proc Natl Acad Sci USA 99: 5283-5288.
20. Robinson NE, Robinson AB. (2001). Proc Natl Acad Sci USA 98: 12409-12413.
21. Samuelson AV, Lowe SW. (1997). Proc Natl Acad Sci USA 94: 12094-12099.
22. Scheffner M, Munger K, Byrne JC, Howley PM. (1991). Proc Natl Acad Sci USA 88: 5523-5527.
23. Shao R, Karunagaran D, Zhou BP, Li K, Lo SS, Deng J et al. (1997). J Biol Chem 272: 32739-32742.
24. Shisler J, Duerksen-Hughes P, Hermiston TM, Wold WSM, Gooding LR. (1996). J Virol 70: 68-77.
25. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collin FS et al. (2002). Proc Natl Acad Sci USA 99: 16899-16903.
26. Takehara T, Takahashi H. (2003). Cancer Res 63: 3054-3057.
27. Uneo NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M et al. (2000). Clin Cancer Res 6: 250-259.
28. Uneo NT, Yu D, Hung MC. (1997). Oncogen 10: 1053-1059.
29. Viniegra JG, Losa JH, Sanchez-Arevalo VJ, Cobo CR, Soria VMF, Cajal SR et al (2002). Oncogene 21: 7131-7136.
30. Wang H, Draetta G, Moran E. (1991). Mol Cell Biol 11: 4253-4265.
31. White E. (1996). Genes Dev 10: 1-15.
32. White E. (2001). Oncogene 20: 7836-7846.
33. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA et al. (1988). Nature 334: 124-129.
34. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. (1993). Cancer Res 53: 891-898.
35. Zhao R, Yang FT, Alexander DR. (2004). Cancer Cell 5: 37-49.